Latest IVF Success Rate Data Shows Reproductive Medicine Associates of New Jersey To Be Among The Top Fertility Programs In The U.S.

BASKING RIDGE, N.J., March 5, 2015 /PRNewswire/ -- Reproductive Medicine Associates of New Jersey (RMANJ), recognized leaders in the research and treatment of infertility, has released in vitro fertilization (IVF) success rates for the year ending December 2013, the most recent data reported by The Society of Assisted Reproductive Technology (SART).

"RMANJ's outstanding IVF success rates reflect a commitment to innovation and excellence by our entire team," said Dr. Michael R. Drews, medical director and a founding partner of RMANJ. "Our holistic approach to patient care, focus on research and dedication to safe and healthy deliveries set us apart," added Dr. Drews from RMANJ's West Orange, New Jersey office.

Determining the right time to start infertility care is a deeply personal decision. Where patients choose to go for care and the treatment options available to them can play a major role delivering a healthy baby. According to the American Society for Reproductive Medicine (ASRM), patients should seek the care of a reproductive specialist if they are unable to achieve pregnancy after 12 months of actively trying to get pregnant, if the female partner is under the age of 35, or after six months if the female partner is older than the age of 35.

"It's important that patients not wait too long to make that first call; age is the biggest factor that impacts infertility. With our recent advancements in screening and treatment protocols, RMANJ is uniquely positioned to help patients across all age groups conceive, on average within four months," said Dr. Thomas Molinaro, a partner at RMANJ and lead physician at the Eatontown, New Jersey office. "At RMANJ, success doesn't stop at conception; we believe success is measured when our patients deliver healthy babies."

"Patients should also be aware of the rate of multiples when analyzing delivery data. It is important to keep in mind that one baby at a time presents the least amount of risk for both mother and child," said Dr. Drews. "At RMANJ, single embryo transfer (SET) with comprehensive chromosome screening (CCS) has resulted in IVF delivery rates above 60 percent with fewer complicated and expensive deliveries that are often the case with multiples. Recently published data from RMANJ showed about a 40 percent savings in the total cost of care from IVF treatment to delivery thanks to SET and CCS."

"There is a lot to learn when you start the IVF process," said Kelly Riley, an RMANJ patient. "One key piece of information patients should look at, before selecting a doctor, is the delivery rates of the facility. After suffering through several miscarriages, this held great importance. I started off with another doctor, but switched to RMANJ once I discovered the success rates were so much higher, and that they offered CCS. I truly believe that is the reason I now have a happy and healthy baby."

RMANJ supports hopeful parents with the widest range of services including IVF, egg donation, gestational surrogacy, CCS, pre-implantation genetic diagnosis (PGD), fertility preservation services, acupuncture, yoga and patient-to-patient networking. As required by the Fertility Clinic Success Rate and Certification Act of 1992, reproductive endocrinologists must report IVF delivery rates to the Centers for Disease Control and Prevention (CDC) and SART, the primary organization of professionals dedicated to the practice of assisted reproductive technologies in the United States.

RMANJ's full 2013 Clinic Summary Report can be viewed at www.sart.org.

About Reproductive Medicine Associates of New Jersey
The fertility experts at RMANJ have among the highest IVF success rates in the country (www.sart.org). Since 1999, they have helped bring more than 30,000 babies to loving families. In addition to serving as the Division of Reproductive Endocrinology at Rutgers Robert Wood Johnson Medical School in New Brunswick, NJ (www.reifellowship.com), the practice has seven locations in New Jersey; Basking Ridge, Eatontown, Englewood, Morristown, Somerset, Summit, and West Orange. RMANJ also is part of the national network of RMA practices in Pennsylvania, New York, Texas, Connecticut, and Michigan.

RMANJ pioneered and successfully implemented a cutting-edge technology, known as Comprehensive Chromosome Screening (CCS), to more accurately detect healthy embryos that have led to successful pregnancies and ultimately healthy babies. Comprehensive Chromosome Screening (SelectCCS) is owned and operated by the Foundation for the Assessment and Enhancement of Embryonic Competence (www.faeec.org), and offers advanced embryo selection with extreme accuracy by detecting and avoiding use of embryos with chromosomal abnormalities prior to transfer and pregnancy.

For more information please call RMANJ at 973-656-2089, or visit www.rmanj.com.

About SART
The Society for Assisted Reproductive Technology, or SART, is the primary organization of professionals dedicated to the practice of assisted reproductive technologies (ART) in the United States. SART includes more than 375 member practices, representing more than 85 percent of the ART clinics in our country. The mission of the organization is to set and help maintain the standards for ART in an effort to better serve its members and patients. One of the most important functions of the SART website is to help patients locate and contact infertility clinics and view national and individual clinic IVF success rates.

Please note a comparison of clinic success rates may not be meaningful because a patient's medical characteristics, treatment approaches and entrance criteria for ART may vary from clinic to clinic.

SOURCE Reproductive Medicine Associates of New Jersey

Related Links

http://www.rmanj.com